Reprise Biomedical, Inc. is focused on the development and commercialization of biological medical devices which offer advanced solutions for healing. Reprise was established as a spin-off from Miromatrix Medical Inc. in July 2019 and took ownership of the manufacturing, marketing, and distribution for two commercially available products, MiroDerm biologic wound matrix and MiroFlex biologic matrix for soft tissue reinforcement. The company is committed to innovation using our proprietary perfusion decellularization technology to develop new medical devices which address unmet surgical needs for healing. Our newest product, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunneling wounds.
Company Details
- Employees
- 46
- Founded
- -
- Address
- Plymouth, Mn - Minnesota 55447, Us
- Phone
- 763-284-6780
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- reprisebio.com
- HQ
- Plymouth, MN - Minnesota
Reprise Biomedical Questions
Reprise Biomedical's helpline number is 763-284-6780
Reprise Biomedical's website is reprisebio.com
Reprise Biomedical's LinkedIn profile is https://www.linkedin.com/company/reprisebio
Reprise Biomedical has
46 employees.
View email and phone details for 46
employees at Reprise Biomedical.
Reprise Biomedical's industry is
Biotechnology Research
Reprise Biomedical's top competitors are
United Therapeutics Corporation,
Lifecore Biomedical,
Monteris Medical,
Purple Surgical,
Luminary Therapeutics, Inc,
Stemonix, Acquired By Axosim,
Vascudyne Inc,
Elucent Medical Inc.,
Vascular Solutions - Now Part Of Teleflex,
Teleflex.
Reprise Biomedical's support email address is info@reprisebio.com
Reprise Biomedical's categories are Biotechnology Research
Reprise Biomedical's founding year is 2019
